Asia Pacific Nerve Repair & Regeneration Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Neurostimulation & Neuromodulation Devices {Internal Neurostimulation Devices [Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Ne

Asia Pacific Nerve Repair & Regeneration Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Neurostimulation & Neuromodulation Devices {Internal Neurostimulation Devices [Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, and Gastric Electrical Stimulation] and External Neurostimulation Devices [Transcutaneous Electrical Nerve Stimulation Devices, Transcranial Magnetic Stimulation Devices, Respiratory Electrical Stimulation Devices]} and Biomaterials), and Application (Neurostimulation & Neuromodulation Applications {Internal neurostimulation & neuromodulation, and External neurostimulation & neuromodulation}, and Nerve Repair & Regeneration Applications {Direct Nerve Repair/Neurorrhaphy [Epineural Repair, Perineural Repair, and Group Fascicular Repair], Nerve Grafting [Autografts, Allografts, and Xenografts], and Stem cell therapy})

The nerve repair & regeneration market in Asia Pacific is expected to grow from US$ 1,266.83 million in 2022 to US$ 2,263.79 million by 2028; it is estimated to grow at a CAGR of 10.2% from 2022 to 2028.

Product Launches and Approvals to Provide Opportunities to Asia Pacific Nerve Repair & Regeneration Market Players

Several nerve repair and regeneration market players are launching various products such as internal neurostimulation devices, external neurostimulation devices, nerve conduits, nerve wraps, nerve connectors, and other biomaterials to enhance the treatment output for nerve repair and regeneration. They are also offering products such as neuromodulators, neurostimulation, and biomaterial devices. These devices are utilized for the treatment of neurodegenerative or traumatic disorders such as Parkinson's disease, Alzheimer's disease, sclerosis, multiple system atrophy, and amyotrophic lateral sclerosis. For instance, in July 2022, Checkpoint Surgical launched the Checkpoint Edge Nerve Cutting Kit, expanding the intraoperative nerve care portfolio of the company. The Checkpoint Edge Nerve Cutting Kit is the first offering in the planned portfolio of nerve-specific instruments by Checkpoint Surgical, with further expansion planned in the future. Further, in March 2022, Integra LifeSciences Holding Corporation launched the NeuraGen 3D Nerve Guide Matrix, which is a resorbable implant for the repair of peripheral nerve discontinuities. NeuraGen 3D is a nerve repair product specifically engineered to develop an optimized environment that enables a greater complete functional recovery following mid-gap nerve repair in comparison to hollow nerve conduits. In August 2021, Checkpoint Surgical, Inc. launched the NeuroShield Chitosan Nerve Wrap to expand its intraoperative nerve care product line. The NeuroShield Wrap marks the company's first product in a planned line of chitosan-based biological implants to support nerve healing. The product complements the existing product portfolio of Checkpoint Surgical, including the company’s flagship Checkpoint Nerve Stimulator/Locator, the leading nerve stimulation device for intraoperative nerve protection and repair. Thus, the active participation of market players in product innovation and development and the increase in approvals of products are likely to fuel the market growth in the coming years.

Market Overview

Asia Pacific is the fastest-growing regional market for nerve repair & regeneration. The Asia Pacific nerve repair & regeneration market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC. Japan has accounted for a 30.8% share of the Asia Pacific nerve repair & regeneration market in 2021, owing to the growing incidence of nerve injuries, high prevalence of neurological disorders, rising medical tourism, and growing government support for research on neurological disorders in the country. These factors are expected to propel the Asia Pacific nerve repair & regeneration market in the coming years.

Asia Pacific Nerve Repair & Regeneration Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Nerve Repair & Regeneration Market Segmentation

The Asia Pacific nerve repair & regeneration market is segmented into product and application.

Based on simulator type, the market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment registered the largest market share in 2022. Based on application, the market is categorized into neurostimulation & neuromodulation applications and nerve repair & regeneration applications. The nerve repair & regeneration applications segment held the largest market share in 2022. Based on country, the Asia Pacific nerve repair & regeneration market is segmented into Australia, China, India, Japan, South Korea, and the Rest of APAC. Japan dominated the market in 2022. Axogen Corporation, Boston Scientific Corporation, Integra LifeSciences, Medtronic, Abbott Laboratories, Stryker Corporation, Neuronetics, LivaNova PLC, Baxter, and Polyganics BV are the leading companies operating in the nerve repair & regeneration market in Asia Pacific.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe airway management devices market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe airway management devices market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the airway management devices market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution